Granda-Díaz et al. [14], in a study of 94 laryngeal dysplasia specimens, demonstrated that SOX2 expression was an independent predictor of laryngeal cancer development (HR = 3.531, 95% CI 1.144 to 10.904; p = 0.028). This evidence concerns the gene SOX2 and laryngeal carcinoma.